Top pathologist Dr. Roger Hodkinson told government officials in Alberta during a zoom conference call that the current coronavirus crisis is “the greatest hoax ever perpetrated on an unsuspecting public.”
Hodkinson’s comments were made during a discussion involving the Community and Public Services Committee and the clip was subsequently uploaded to YouTube.
Noting that he was also an expert in virology, Hodkinson pointed out that his role as CEO of a biotech company that manufactures COVID tests means, “I might know a little bit about all this.”
“There is utterly unfounded public hysteria driven by the media and politicians, it’s outrageous, this is the greatest hoax ever perpetrated on an unsuspecting public,” said Hodkinson.
The doctor said that nothing could be done to stop the spread of the virus besides protecting older more vulnerable people and that the whole situation represented “politics playing medicine, and that’s a very dangerous game.”
Hodkinson remarked that “social distancing is useless because COVID is spread by aerosols which travel 30 meters or so before landing,” as he called for society to be re-opened immediately to prevent the debilitating damage being caused by lockdowns.
Hodkinson also slammed mandatory mask mandates as completely pointless.
“Masks are utterly useless. There is no evidence base for their effectiveness whatsoever,” he said.
“Paper masks and fabric masks are simply virtue signalling. They’re not even worn effectively most of the time. It’s utterly ridiculous. Seeing these unfortunate, uneducated people – I’m not saying that in a pejorative sense – seeing these people walking around like lemmings obeying without any knowledge base to put the mask on their face.”
The doctor also slammed the unreliability of PCR tests, noting that “positive test results do not, underlined in neon, mean a clinical infection,” and that all testing should stop because the false numbers are “driving public hysteria.”
Hodkinson said that the risk of death in the province of Alberta for people under the age of 65 was “one in three hundred thousand,” and that it was simply “outrageous” to shut down society for what the doctor said “was just another bad flu.”
“I’m absolutely outraged that this has reached this level, it should all stop tomorrow,” concluded Dr. Hodkinson.
Hodkinson’s credentials are beyond question, with the MedMalDoctors website affirming his credibility.
“He received his general medical degrees from Cambridge University in the UK (M.A., M.B., B. Chir.) where he was a scholar at Corpus Christi College. Following a residency at the University of British Columbia he became a Royal College certified general pathologist (FRCPC) and also a Fellow of the College of American Pathologists (FCAP).”
“He is in good Standing with the College of Physicians and Surgeons of Alberta, and has been recognized by the Court of Queen’s Bench in Alberta as an expert in pathology.”
In case the above video gets deleted by YouTube, a backup via Bitchute is available here.
* * *
Is Biotech ripe for investment yet?
It’s a great time to be looking for opportunities in biotech as the sector is near the bottom, says MPM Capital’s Dr Christiana Bardon. Biotech has…
It’s a great time to be looking for opportunities in biotech as the sector is near the bottom, says MPM Capital’s Dr Christiana Bardon.
Biotech has been in correction over the past eight months
What many see as a sharp decline in biotech, Dr Bardon dubs an overdue correction after a prolonged period of “too much enthusiasm” due to the COVID pandemic. Speaking with CNBC’s Leslie Picker, she said:
The long-term prospects for this industry look as great as ever. The demographics of the aging population means we’ll need new drugs, the support of regulatory environment, and finally the third fundamental is innovation at record high levels.
The iShares Biotech ETF is down 25% from its high in August 2021, but Dr Bardon is focused on the long term. She sees an upward trend in biotech over the next thirty years.
Dr Bardon is particularly interested in Oncology within Biotech
According to the Harvard-trained medical doctor, investors should focus on areas within Biotech that are committed to addressing unmet medical needs, such as Oncology. She added:
Oncology continues to be an exciting area of Biotech. Within Oncology, we’re seeing incredible innovation primarily because of the genomics revolution. And then the regulatory environment is very supportive of cancer drug development.
Dr Bardon sees the U.S. as a global leader in biotech and reiterates that it was this industry that helped the world pull out of the Coronavirus crisis.etf pandemic coronavirus
ironSource CEO: gaming is more than just a COVID play
The VanEck Video Gaming and eSports ETF (ESPO) is up nearly 100% since the start of the pandemic, and ironSource Ltd (NYSE: IS) CEO Tomer Bar Zeev doesn’t see an end to this trend in the near future. Highlights from Zeev’s interview on CNBC’s ‘TechCheck’.
The VanEck Video Gaming and eSports ETF (ESPO) is up nearly 100% since the start of the pandemic, and ironSource Ltd (NYSE: IS) CEO Tomer Bar Zeev doesn’t see an end to this trend in the near future.
Highlights from Zeev’s interview on CNBC’s ‘TechCheck’
Zeev agrees that video gaming and eSports was a beneficiary of the global pandemic but says the segment is now much more than just a COVID play. On CNBC’s “TechCheck”, he said:
When COVID started, we saw an uptick of roughly 10% in the time that users spent within games. As the world reopened, it pretty much stayed the same. So, we think it’s the new norm. We don’t think we’ll see any change in that regard.
According to Statista, much of the increase in hours spent on video games was attributed to the new gamers in 2020 who turned to the industry in search of indoor means of entertainment amidst COVID restrictions.
Gaming is bigger than film and music combined
According to Zeev, gaming is the fastest-growing segment within the app economy, and it will continue to lead the industry on growth in gaming library as well as relevant platform software.
The gaming ecosystem within the app economy is growing super-fast. Gaming is the biggest part of the app economy, it’s bigger than the film industry and the music industry combined. So, it makes perfect sense that it will grow all around. It will continue to lead the app economy.
Earlier this week, Take-Two Interactive said it will buy Zynga Inc for $12.70 billion in cash and stock to expand its footprint in mobile gaming. Zeev expects such consolidation to continue as companies move to benefit from the fast-growing gaming economy.
The post ironSource CEO: gaming is more than just a COVID play appeared first on Invezz.etf pandemic
Omicron is not a threat for the retail sector in the short-term
Investors are responding rather strongly to reports of a new COVID variant of concern the WHO designated “Omicron” on Friday. But the former Walmart CEO Bill Simon is confident it doesn’t pose much of a threat for the retail sector in the short…
Investors are responding rather strongly to reports of a new COVID variant of concern the WHO designated “Omicron” on Friday. But the former Walmart CEO Bill Simon is confident it doesn’t pose much of a threat for the retail sector in the short term.
Simon’s remarks on CNBC’s ‘Closing Bell’
Bill expects consumer strength and holiday season to help the retail sector absorb this news with minimal reaction. On CNBC’s “Closing Bell”, he said:
People were out shopping today, looking for deals. Stores were crowded, prices were very good and aggressive, particularly in the big-box chains. So, in the short run, with the Black Friday weekend and everything else going on, I don’t think you’ll see much of a reaction.
He refrained from commenting on the long-term impact of the new variant on the retail sector and said it would depend on how the situation unravels. The SPDR S&P Retail ETF is down more than 3.0% on Friday.
Retail has been divided into winners and losers
During the same interview, BMO Capital Markets’ Simeon Siegel said the retail sector was no longer moving in unison; the pandemic had split it into winners and losers.
The question is, who has the pricing power versus who saw fewer promotions. All of them will deal with externalities, whether it’s the variant or the supply chain. But what brands actually structurally improved their business through the pandemic; that’s the dynamic.
According to Siegel, the recent earnings season already made this division evident. On the one hand, we had companies like Capri Holdings that jumped about 20% after reporting results for the latest quarter, and on the other, there was Nordstrom that was down the same after its quarterly report.
The post Omicron is not a threat for the retail sector in the short-term appeared first on Invezz.etf pandemic
Spread & Containment18 hours ago
Kim Jong Un Was ‘Seriously Ill’ With COVID, Blames S.Korea For Sending Tainted Objects Across Border
Economics8 hours ago
REVEALED: THE INCREASE IN CANADA’S SOCIAL VALUE FROM GETTING MORE ACTIVE
Government23 hours ago
Epic Collapse Is Upon Us
Government14 hours ago
Tax revenues are on the moon; why double the IRS?
Economics22 hours ago
Commercial Gaming Revenue Reaches $14.8B in Q2 2022, Sets All-Time Quarterly High
Crypto13 hours ago
ASIC chair troubled by sheer amount of ‘risk-taking’ crypto investors
Science21 hours ago
Reframe the pain: Reducing needle anxiety in children
Stocks21 hours ago
Stocks Fumble As Bulls Fail To Hold Critical 50% Retracement